Benitec Ends Royalty Obligations to CSIRO in Exchange for 10 Percent Stake

Benitec said that it has also re-obtained a royalty stream paid by Sigma-Aldrich stemming from a license to its expressed RNAi technology for use in making and selling research products.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.